Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

47.00p

Change Today:

-6.50p
52 Week High: 262.50
52 Week Low: 46.00

Currency: UK Pounds
Shares Issued: 115.78m
Volume: 190,376

Market Cap: £54.42m
Beta: 0.02

Trade now with Barclays Stockbrokers

Update - Faron Pharmaceuticals Oy (DI) is down today can you capitalise from spread betting? Find out more
Update - Faron Pharmaceuticals Oy (DI) is a top faller in its sector - can you take advantage with spread betting? Find out more

FARN Overview

We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.

1 Day Chart (11-03-2026)

6 Month Chart

More Faron Pharmaceuticals Oy (DI) charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-1449.5%	n/a
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	51.9	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	n/a	n/a
PBT	n/a	n/a
EPS	n/a	16.4%
DPS	n/a	n/a

FARN Fundamentals

Year Ending	Revenue ( m)	Pre-tax ( m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	n/a	(21.18)	(42.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	n/a	(28.73)	(52.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	n/a	(30.94)	(48.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	n/a	(25.92)	(29.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	1.31	(27.25)	(24.00)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FARN Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-26	n/a	(31.35)	(24.30)p	n/a	n/a	+16%	n/a	0.0%
31-Dec-27	36.05	(18.45)	(20.54)p	n/a	n/a	+n/a	n/a	0.0%

Faron Pharmaceuticals Oy (DI) forecasts

FARN Company Announcements

The Finnish Financial Supervisory Authority has ...	11-Mar-2026	18:20	RNS
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY	11-Mar-2026	08:00	RNS
Inside Information: Faron publishes the terms an...	10-Mar-2026	07:48	RNS

More Faron Pharmaceuticals Oy (DI) farn company announcements

FARN ShareCast News

Inside Information: Faron publishes the terms an...	10-Mar-2026	ShareCast
Director dealings: Victoria non-exec invests, Fa...	13-Jan-2026	ShareCast
Faron issuing second tranche of unsecured conver...	11-Dec-2025	ShareCast

More Faron Pharmaceuticals Oy (DI) ShareCast news

Latest FARN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

FARN Market Data

Currency	UK Pounds
Share Price	47.00p
Change Today	-6.50p
% Change	-12.15 %
52 Week High	262.50
52 Week Low	46.00
Volume	190,376
Shares Issued	115.78m
Market Cap	£54.42m
Beta	0.02